Emcure Pharma Buys 12.05% Stake in Gennova, Now Wholly Owned

Emcure Pharmaceuticals Limited has consolidated its ownership in its biopharma subsidiary, Gennova Biopharmaceuticals Limited, by acquiring the entire 12.05% minority stake held by Dr. Sanjay Singh and others. This move makes Gennova a wholly owned subsidiary of Emcure. The company is sharpening its focus on biologics and biosimilars, with Gennova now under the leadership of Mr. Samit Mehta. Gennova will concentrate on its biologics franchise, biosimilars development, and adjacent therapeutic platforms. Emcure stated that this transaction is not expected to materially impact its consolidated financials or capital allocation framework, with deleveraging, capex, and R&D plans remaining unchanged.